Clinical Efficacy of Dienogest and Levonorgestrel-Releasing Intrauterine System in the Treatment of Adenomyosis

Objective: To compare the clinical efficacy and adverse reactions of dienogest levonorgestrel-releasing intrauterine system in treatment adenomyosis. Methods: A total 60 cases adenomyosis admitted to Dezhou Women Children’s Hospital from January 2020 October 2021 were selected randomly divided into two groups (Group Group B), which initiated on system, respectively. The therapeutic effects analyzed. Results: After 6 months treatment, uterine volume LNG-IUS group reduced slightly compared with that before no statistical significance (p > 0.05), while DNG increased 0.05). hemoglobin patients both treatment; there was significant difference but < 0.01). VAS scores significantly lower than those 0.01); serum CA125 level decreased Conclusion: Mirena (levonorgestrel-releasing system) has better effect fewer deinogest.